Contact the ACC Registration and Housing Center

  • 864-208-2670
  • M-F, 9:00 a.m. - 5:00 p.m. ET
  • ACC@maritz.com

  • Accreditation

    Educational Need and Goals

    Statement of Educational Need/Purpose

    Cardiovascular disease (CVD) remains the leading cause of death throughout the world. ACC.22 will focus on late breaking science with interactive, innovative education to improve cardiovascular care. Now, more than ever, a global health perspective is critical for cardiovascular clinicians, and ACC.22 will reimagine global health in this ever-changing era. With live, in-person and virtual programming, ACC.22 will reach a global audience, providing access to the latest science and advances in CVD. ACC.22 and ACC.22 Virtual will also provide perspectives from around the world to share best practices in cardiovascular care and facilitate incorporation of practical solutions for all members of the cardiovascular care team. At ACC.22 all members of the cardiovascular care team will receive essential education highlighting ongoing research to improve cardiovascular outcomes and address challenges with implementation of evidence-based guidelines.

    Educational Program Goals

    Through our educational content we aim to:

    1. Promote cardiovascular science and education to a global audience
    2. Provide a stimulating environment for sharing new knowledge, presentation of research, networking, and collaboration with a goal of improving cardiovascular disease management for all patients
    3. Facilitate translation of cardiovascular science to all members of the care team leading to high-quality, patient-centered care
    4. Promote the use of new technologies to improve the delivery of healthcare in a dynamic environment
    5. Address inequities in health care
    6. Allow for examination and discussion of important contributions and controversies in cardiovascular care
    7. Integrate traditional and novel educational techniques and create an interactive and informative learning environment

    As a result of participating in the Electrophysiology Pathway sessions, learners will have an improved or reinforced ability to:

    1. Apply recent evidence and current guideline recommendations to the management of all types of cardiac arrhythmias
    2. Integrate and evaluate emerging evidence and options for prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation
    3. Identify different patient populations that may benefit from contemporary device-based therapies
    4. Compare and contrast management and treatment of arrhythmias, including outcomes and risk of adverse events due to medications used to treat arrhythmias
    5. Recognize and interpret common ECG patterns and integrate this knowledge into clinical decision-making by the practitioner for a cardiovascular disease patient
    6. Provide up-to-date management of arrhythmias in special populations, including in pregnant women, athletes, older adults, cancer patients, and those with heart failure
    7. Debate topical and global health trends and advancing technology in the treatment of atrial fibrillation
    8. Evaluate emerging therapies for arrhythmia care and research in the context of artificial intelligence and wearable technology

    As a result of participating in the Heart Failure and Cardiomyopathies Pathway sessions, learners will have an improved or reinforced ability to:

    1. Provide current best care for heart failure patients using evidence-based therapies and consensus guidelines for diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy
    2. Offer practical guidance on diet, exercise, and heart failure management that is appropriately tailored to diverse patient populations across various stages and types of heart failure
    3. Recognize the interaction between various comorbidities, including diabetes, obesity, frailty, chronic kidney disease, and heart failure, and best practices in the multidisciplinary approach
    4. Expand knowledge about the management of patients with specific etiologies of cardiomyopathy such as hypertrophic, peripartum, infiltrative and arrhythmogenic cardiomyopathies
    5. Analyze the evidence on current and newer pharmacotherapies, monitoring and therapeutic devices, towards prioritization and best practices in heart failure management
    6. Develop greater insight into the current state of knowledge in cardio-oncology, cardiogenic shock, and cardiac amyloidosis
    7. Expand or update their knowledge of advanced heart failure treatment options, which patients should be referred to specialized centers, and advanced care planning

    As a result of participating in the Interventional and Structural Pathway sessions, learners will have an improved or reinforced ability to:

    1. Evaluate the evidence from interventional and structural clinical trials describing strategies and outcomes and incorporating the evidence into clinical practice
    2. Understand the risks/benefits of interventional and structural procedures in a pregnant patient and how best to mitigate the associated risk
    3. Determine an appropriate antithrombotic regimen for patients undergoing structural procedures
    4. Determine appropriate antithrombotic regimens for diverse patients with acute coronary syndrome or those undergoing a revascularization procedure
    5. Determine an appropriate antithrombotic regimen for patients at high risk for bleeding undergoing a revascularization procedure
    6. Determine an appropriate antithrombotic regimen for patients with atrial fibrillation and acute coronary syndromes undergoing revascularization procedures
    7. Understand critical decisions making techniques for revascularization of patients who are high-risk or have complex coronary artery disease
    8. Appropriately incorporate state-of-the-art complex coronary techniques and technologies into patient care
    9. Describe the fundamentals of chronic total occlusion procedures
    10. Describe strategies for preventing and managing interventional complications
    11. Incorporate innovative strategies, technologies, and techniques to optimize coronary interventions
    12. Interpret and integrate findings from intravascular imaging and hemodynamic lesion assessment into clinical and technical decision-making approach to complex coronary interventions
    13. Interpret and integrate findings from invasive hemodynamic lesion assessment into clinical decision-making for acute coronary syndrome
    14. Incorporate innovative strategies, technologies, and techniques to guide cardiac catheterization lab-based management of patients with angina
    15. Interpret and integrate invasive coronary and ventricular physiology into clinical decision-making for aortic stenosis
    16. Describe appropriate management strategies in patients with cardiogenic shock
    17. Describe the gaps and disparities in care of patients presenting with cardiogenic shock
    18. Describe management of patients with cardiogenic shock after they have a mechanical hemodynamic support device implanted
    19. Describe appropriate case selection for mechanical hemodynamic support in cardiogenic shock
    20. Describe how to effectively create a comprehensive heart team approach in the management of complex cardiac patients
    21. Appropriately incorporate state-of-the-art endovascular technologies and techniques into patient care
    22. Describe how to build an effective endovascular practice
    23. Discuss how to improve outcomes in patients with critical limb ischemia
    24. Describe optimal management strategies in patients with pulmonary embolism
    25. Appropriately incorporate state-of-the-art technologies and techniques in patients undergoing non-valvular structural heart interventions
    26. Discuss the current controversies in patients undergoing transcatheter aortic valve replacement
    27. Appropriately incorporate state-of-the-art technologies and techniques for patients undergoing transcatheter mitral and tricuspid valve therapies
    28. Demonstrate cases using innovative technologies in the cardiac catheterization lab
    29. Understand the expanding indications for catheter based mitral valve therapies and appropriately incorporate new and state-of-the-art techniques and technologies during transcatheter mitral valve repair
    30. Understand the expanding indications for catheter-based valve interventions for all but the aortic valve and appropriately incorporate new and state-of-the-art techniques and technologies during non-aortic valve interventions

    As a result of participating in the Ischemic Heart Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Provide comprehensive contemporary care to patients presenting with ST-elevation myocardial infarction (STEMI)
    2. Apply appropriate cardiovascular testing and risk assessment tools to patients in need of preoperative cardiovascular evaluation prior to non-cardiac surgery; guide peri-operative management for patients at the time of non-cardiac surgery
    3. Identify disparities in cardiovascular care that stem from lifestyle and pharmaceutical barriers and discuss potential solutions in the management of stable ischemic heart disease
    4. Compare and contrast global approaches to systems of care for treatment of STEMI
    5. Review recent studies that impact the care of patients with ischemic heart disease
    6. Define and identify social determinants of health that impact patients with ischemic heart disease and list ways to mitigate the impact
    7. Highlight recruitment strategies, contemporary evidence, advocacy approaches and care optimization in cardiac rehabilitation
    8. Describe new opportunities in the use of telehealth to optimize contemporary ischemic heart disease care
    9. Describe the best use of high sensitivity troponin and the appropriate management of acute and chronic chest pain
    10. Assess and appropriately manage patients with cardiogenic shock
    11. Optimize anti-platelet therapy for patients with acute and stable ischemic heart disease
    12. Describe risk factors for spontaneous coronary artery dissection (SCAD); discuss acute and long-term management of patients with SCAD; list SCAD resources for patients
    13. Diagnose and manage myocardial infarction with non-obstructive coronary arteries (MINOCA) and ischemia with non-obstructive coronary arteries (INOCA)
    14. Identify risk factors for as well as the diagnostic and therapeutic approaches to myocardial ischemia and infarction during pregnancy
    15. Discuss management options for left main coronary artery disease, including risk and benefits of each
    16. Weigh risks and benefits to revascularization approaches in situations that fall outside traditional guideline management
    17. Describe newly identified risk factors for atherosclerotic cardiovascular disease (ASCVD) as well as novel approaches to traditional ASCVD risk factor management
    18. Provide optimal management of patients with stable ischemic heart disease who are >80 years old
    19. Discuss the utility of cardiac CT in management of ischemic heart disease
    20. Discuss current evidence for the use of complementary and alternative medicine approaches for the management of stable ischemic heart disease

    As a result of participating in the Multimodality Imaging Pathway sessions, learners will have an improved or reinforced ability to:

    1. Apply current imaging guidelines for the assessment of valvular, myocardial, coronary, and structural heart diseases
    2. Identify both current and emerging role of imaging in Sarcoidosis and viability testing
    3. Evaluate recent innovations and established techniques in advanced imaging and their potential uses in complex disorders such as microvascular disease and cardiomyopathies
    4. Appreciate the future of cardiovascular imaging by understanding the role of artificial intelligence
    5. Recognize the utility of multimodality imaging in the management of patients who require structural interventions
    6. Understand the role of non-invasive imaging in special populations such as cardio-oncology, athletes and COVID-19 infections

    As a result of participating in the Pediatric and Congenital Heart Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Identify strategies to effectively evaluate and manage congenital heart disease throughout the lifespan from childhood to adult life
    2. Recognize obstacles and challenges to careers in pediatric cardiology and cardiac surgery
    3. Critically evaluate how teams approach problem-solving in a variety of clinical settings including in the imaging lab, the cardiac intensive care unit, the cardiac catheterization lab, the operating room, and in unique settings and how quality and performance metrics can support these activities
    4. Recognize the value and challenges of mechanical circulatory support in children and adolescents
    5. Incorporate the experiences of teams who care for children across the globe into our practices
    6. Identify the burden of non-cardiac and systemic disease in children and adults living with congenital heart disease
    7. Describe new innovations in the treatment of children and adults with congenital heart disease
    8. Recognize the challenges of treatment of complex arrhythmia problems in pediatric cardiology
    9. Identify new basic science mechanisms that are now being applied at the bedside for pediatric heart failure
    10. Describe elements in multimodality cardiovascular imaging and knowledge base required to support decision-making in congenital heart disease

    As a result of participating in the Prevention and Health Promotion Pathway sessions, learners will have an improved or reinforced ability to:

    1. Recognize the value of nutrition in promotion of cardiovascular health and understand the evidence that supports various dietary approaches
    2. Understand the management of cholesterol problems across the lifespan
    3. Review, learn and understand various aspects of cardiovascular disease prevention
    4. Apply and learn the current evidence-based approach to manage hypertension
    5. Appreciate the interplay between diabetes, obesity, inflammation and cardiometabolic risk and how to tailor management strategies based on available evidence
    6. Learn the process of setting up a cardio metabolic clinic
    7. Recognize the importance of pregnancy, peripartum and maternal health in cardiovascular disease prevention
    8. Learn state-of-the-art approaches in the management of elevated LDL-cholesterol and be informed of further research in this area
    9. Understand the adverse health impact of elevated triglycerides and learn the contemporary approaches in the management of elevated triglycerides
    10. Understand and learn about the approaches to manage obesity
    11. Learn about challenges and disparities in the global approaches in managing hypertension
    12. Integrate best practices with regards to lifestyle and dietary recommendations to prevent or manage ASCVD and related diseases, such as diabetes
    13. Recognize the importance of physical activity in cardiovascular disease prevention
    14. Review the importance of cardiac rehabilitation and discuss other aspects such as smoking, sex and depression in patients with cardiovascular disease
    15. Appreciate the value of exercise, meditation, smoking cessation, diet and exercise in optimizing cardiovascular risk
    16. Recognize the increasing burden of cardiovascular disease in individuals of south Asian ancestry and learn about preventive approaches in them
    17. Appreciate the importance of inflammation in cardiovascular disease and learn about approaches that have been and are being tested to treat the same
    18. Recognize and learn about factors to consider in young patients with atherosclerotic cardiovascular events
    19. Recognize the importance of lipoprotein(a) in atherosclerotic cardiovascular disease and learn about approaches in managing the same
    20. Learn about challenging populations and approaches to manage hyperlipidemia in these populations

    As a result of participating in the Pulmonary Vascular Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Recognize novel risk factors for the development of pulmonary vascular disease
    2. Understand the diagnostic approach to patients with echocardiography results suggesting pulmonary hypertension
    3. Understand the management of patients with pulmonary hypertension occurring under special clinical circumstances
    4. Utilize cutting-edge clinical trial data to optimize outcomes in patients with pulmonary hypertension
    5. Use state-of-the-art information to manage and prognosticate patients with right ventricular dysfunction needing surgery or critical care
    6. Discover new opportunities to treat pulmonary vascular disease using drug therapies used currently for other indications

    As a result of participating in Valvular Heart Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Apply recent updates to guidelines and recommend best practices for valvular care to clinical practice
    2. Recognize the importance of, the benefits, and the difficulties associated with a heart team approach
    3. Incorporate the use of multimodality imaging and machine learning to evaluate patients with valvular heart disease
    4. Incorporate the natural history of, diagnostic imaging, and treatment modalities in the lifelong management of valvular heart disease
    5. Apply knowledge on managing valvular heart disease patients pre and post procedure
    6. Recognize the importance of diagnosing and managing patients with tricuspid regurgitation
    7. Recognize the difficulties in managing patients with severe calcific mitral disease
    8. Apply knowledge on managing anticoagulation in patients with valvular heart disease
    9. Recognize the dilemmas in managing nonagenarian patients with valvular heart disease

    As a result of participating in the Vascular Medicine Pathway sessions, learners will have an improved or reinforced ability to:

    1. Describe the contemporary medical and surgical management of aortic disease
    2. Delineate the role of health disparities in the management and outcome of patients with peripheral artery disease
    3. Discuss strategies to reduce health disparities among patients with vascular disease
    4. Evaluate the role of multidisciplinary teams in the evaluation and treatment of intermediate and high-risk acute pulmonary embolism
    5. Describe the complexities in the medical management of peripheral artery disease in patients with polyvascular disease and other conditions associated with high cardiovascular risk
    6. Recognize the common presentations and evaluation strategies for common and uncommon vascular diseases

    The deadline to claim credit was May 1, 2022, at 5 p.m. ET.

    Jointly Accredited

    In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Physicians

    The ACCF designates this Other activity (Live and On-Demand) for a maximum of 70.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABIM and ABP MOC

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to

    • 70.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
    • 70.00 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program.

    It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

    Nurses

    The ACCF designates this educational activity for a maximum of 70.00 continuing nursing education contact hours and 32.50 pharmacotherapeutic nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

    Physician Assistants

    The American College of Cardiology Foundation has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 70.00 AAPA Category 1 CME credits.

    Pharmacists

    ACCF designates this continuing education activity for 70.00 contact hours (70 CEUs) of the Accreditation Council for Pharmacy Education.

    European Board for Accreditation in Cardiology (EBAC) External CME Credit The activity "ACC 71st Annual Scientific Session" is accredited by the European Board for Accreditation in Cardiology (EBAC) for External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME) and the European Board for Accreditation in Cardiology (EBAC) have recognized each other's accreditation systems as substantially equivalent.

    ACCF designates this continuing education activity for a maximum of 70.00 credits toward the European Board for Accreditation in Cardiology (EBAC).

    Please note: VNR numbers are not available or required this year, participants will receive a certificate of credit as proof of participation in the certified activity.

    Interprofessional Continuing Education

    This activity was planned by and for the healthcare team, and learners will receive up to 31.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

    As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

    ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

    ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations. ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.

    Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.

    ADVERTISEMENT
    American College of Cardiology

    © 2022 American College of Cardiology Foundation. Visit ACC.org

    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us